Nirogy Therapeutics
Natick
About Nirogy Therapeutics
Nirogy Therapeutics is a biotechnology company developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncology as well as autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $18.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2021)
- Website: nirogytx.com
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nirogy-therapeutics-91440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.